Squarepoint
IMVT icon

Squarepoint’s Immunovant IMVT Stock Holding History

Squarepoint’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3M Buy
+77,769
New +$2.37M ﹤0.01% 2009
2025
Q3 		– Sell
-84,919
Closed -$1.36M – 4642
2025
Q2 		$1.36M Buy
84,919
+74,494
+715% +$1.13M ﹤0.01% 2393
2025
Q1 		$178K Buy
+10,425
New +$218K ﹤0.01% 4055
2024
Q3 		– Sell
-49,288
Closed -$1.3M – 4372
2024
Q2 		$1.3M Buy
49,288
+2,615
+6% +$74.4K ﹤0.01% 2367
2024
Q1 		$1.51M Buy
+46,673
New +$1.7M ﹤0.01% 2292
2023
Q4 		– Sell
-14,587
Closed -$560K – 4237
2023
Q3 		$560K Buy
+14,587
New +$330K ﹤0.01% 2713
2023
Q2 		– Sell
-93,895
Closed -$1.46M – 3769
2023
Q1 		$1.46M Buy
93,895
+58,943
+169% +$1.02M 0.01% 1634
2022
Q4 		$620K Buy
+34,952
New +$440K ﹤0.01% 2147
2022
Q2 		– Sell
-28,037
Closed -$154K – 3101
2022
Q1 		$154K Sell
28,037
-39,879
-59% -$248K ﹤0.01% 2540
2021
Q4 		$579K Sell
67,916
-10,364
-13% -$85.6K ﹤0.01% 2049
2021
Q3 		$680K Buy
78,280
+42,874
+121% +$387K ﹤0.01% 1790
2021
Q2 		$374K Sell
35,406
-11,439
-24% -$160K ﹤0.01% 2360
2021
Q1 		$751K Buy
46,845
+24,458
+109% +$645K ﹤0.01% 1733
2020
Q4 		$1.03M Buy
22,387
+4,777
+27% +$221K 0.01% 1309
2020
Q3 		$620K Buy
+17,610
New +$530K 0.01% 1267

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Squarepoint's IMVT Position: Q2 2026 in Review

Squarepoint opened a new position in Immunovant (IMVT) in Q2 2026: 77,769 shares worth $3M. The stake represents ﹤0.01% of the portfolio and ranks #2009 among its holdings. This is a return to the name: Squarepoint previously reported a position in IMVT as recently as Q2 2025.

Squarepoint first reported a position in IMVT in Q3 2020 and has held it in 15 quarters since. 227 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Squarepoint held 77,769 shares of Immunovant worth $3M as of Q2 2026.
  • Immunovant was a new Squarepoint position in Q2 2026.
  • Immunovant made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #2009 holding.
  • Squarepoint first reported a position in Immunovant in Q3 2020 and has held it in 15 quarters since.
  • 227 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.